Cat.#: ACPP-1324
| Despition | Insulin Receptor Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1230 | MC3 Receptor Blocking Peptide (AC1230) | 250 µg | inquiry |
| ACPP-1308 | TrkA Blocking Peptide (AC1308) | 250 µg | inquiry |
| ACPP-1401 | Rat Midkine Protein (AC1401) | 5 µg | inquiry |
| ACPP-1805 | Human NTS Protein (AC1805) | 5 µg | inquiry |
| ACPP-1785 | Human NEUROG3 Protein (AC1785) | 2 µg | inquiry |
| ACPP-1238 | LIMK1 Blocking Peptide (AC1238) | 250 µg | inquiry |
| ACPP-1280 | SRPX2 Blocking Peptide (AC1280) | 250 µg | inquiry |
| ACPP-1607 | Mouse Leptin Protein, PEG (AC1607) | 20 µg | inquiry |
| ACPP-1757 | Human Artemin Protein (AC1757) | 5 µg | inquiry |
| ACPP-1012 | Recombinant Human Ninjurin 1 Protein (Fc Tag) (AC1012) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.